DSD-T109
Congenital adrenal hyperplasia (CAH) · 45,X/46,XY · DSD-T109
46,XY 17α-hydroxylase/17,20-lyase deficiency (compound heterozygous CYP17A1 variants) with low-renin hypertension.
Case fields and evidence
- Category
-
Congenital adrenal hyperplasia (CAH)
- Age
-
First visit at 16 years 1 month; diagnosed at 17 years; gonadectomy at 18 years 5 months.
- Sex
-
Raised as female, female gender identity.
- Karyotype
-
45,X/46,XY
- Phenotypes
-
Infertility (HP:0000789)
- Diagnosis
-
46,XY 17α-hydroxylase/17,20-lyase deficiency (compound heterozygous CYP17A1 variants) with low-renin hypertension.
- Follow-up
-
During hospitalization blood pressure improved markedly to 113/51 mmHg after switching to dexamethasone; glucocorticoid and estrogen replacement therapy were continued
- General phenotype
-
Female phenotype with female external genitalia and blind vagina, breast Tanner II, pubic hair Tanner I, mild vulvar hyperpigmentation, and no history of adrenal crisis.
- Imaging
-
Pelvic MRI showed absent uterus and ovaries and small bilateral inguinal gonads (<2 cm). Adrenal CT showed no obvious enlargement.
- Laboratory findings
-
Testosterone <3 ng/dL, LH 14.8→21.0 mIU/mL, FSH 17.57→22.40 mIU/mL, estradiol 15.4→8.4 pg/mL, progesterone 4.28 ng/mL, ACTH 99.1→103.0 pg/mL, DHEAS 55→46 ng/mL, cortisol 0.8→1.2 µg/dL, aldosterone <0.40 ng/dL, renin activity <0.2 ng/mL/h. No response to hCG and hMG stimulation; on ACTH stimulation testing cortisol was 1.2/1.8 µg/dL. Urinary steroid profile showed elevated pregnenolone, progesterone, DOC and corticosterone metabolites and decreased androgen metabolites.
- Management
-
Transdermal estradiol patch; hydrocortisone replacement after diagnosis; bilateral gonadectomy at 18 years 5 months; because of poor blood pressure control treatment was changed to dexamethasone, and blood pressure fell to 113/51 mmHg.
- Pathology
-
The bilateral gonadectomy specimens measured 12 mm and 11 mm in maximum diameter; pathology showed immature testes containing immature Sertoli cells and Leydig cells, with no malignant changes.
- Evidence level
-
See source
- Clinical history
-
See source
- External genital examination
-
See source
- Limitations
-
See source
- Perinatal history
-
See source
- Family history
-
See source
- Growth and development
-
See source
- Genetics
-
See source
Cite this resource
DSD Research Library | Congenital adrenal hyperplasia (CAH) · 45,X/46,XY · DSD-T109 | v1.4.0 | 2026-11-17 | https://dsdatlas.com/en/cases/DSD-T109?version=v1.4.0